Tokyo, Japan

Maiko Iida

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Yokohama, JP (2014)
  • Tokyo, JP (2015 - 2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Maiko Iida: Innovator in Cardiovascular and Cancer Treatment

Introduction

Maiko Iida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the fields of cardiovascular and cancer treatment through her innovative research and development of new compounds. With a total of 3 patents to her name, Iida's work is paving the way for advancements in medical therapies.

Latest Patents

One of her latest patents involves imidazopyridine compounds, which are recognized for their potential in treating or preventing cardiovascular diseases. These compounds enhance cGMP production through soluble guanylate cyclase activation. Specifically, the imidazopyridine compounds with a carbamoyl group at the 3-position and a substituent at the 8-position exhibit a potent action that is beneficial for various cardiovascular conditions. Another notable patent is for a pyrazinecarboxamide compound, which is useful in treating cancer in patients expressing the EGFR T790M mutation.

Career Highlights

Throughout her career, Maiko Iida has worked with reputable companies such as Astellas Pharma GmbH and Meiji Seika Pharma Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Iida has collaborated with notable colleagues, including Yuji Koga and Kyoichi Maeno. These partnerships have fostered an environment of innovation and have led to the development of her impactful patents.

Conclusion

Maiko Iida's contributions to the medical field through her patents and collaborations highlight her role as a leading inventor in the treatment of cardiovascular diseases and cancer. Her work continues to inspire advancements in pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…